| 15-Sep-2020 | Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients With Advanced Lung Adenocarcinoma | Guo, Long-Hua; Zhang, Ming-Feng; Zhang, He-Long; Zhou, Jian-Ying; Cai, Xiao-Hong; Long, Yu; Guo, Qi-Sen; Yang, Nong; Zhao, Jun; Xie, Zhan-Hong; Jiang, Bo; Zhu, Ying; Fan, Yun; Xie, Cong-Ying; Hu, Yi; Yao, Yu; Jia, Jun; Li, Xiao-Ling; Cui, Jiu-Wei; Sui, Xi-Zhao; Lin, Wen; Cheng, Ying; Wang, Hui-Juan; Wang, Chang-Li; Zhao, Ming-Fang; Qiao, Gui-Bin; Peng, Li-Jun; Yang, Lin; Chen, Gong-Yan; Cai, Kai-Can; Xu, Xin-Hua; Zhang, Liang-Ming; Feng, Guo-Sheng; Zhou, Jing-Min; Wu, Guo-Wu; Dong, Xiao-Rong; Wang, Li-Feng; Zhang, Hong-Mei; Gao, Ya-Jie; Jiang, Qiu-Ying; Cang, Shun-Dong; Yang, Zhi-Xiong; Song, Xia; Liu, Xiao-Qing; Zhu, Bo; Chen, Feng-Xia; Hu, Chun-Hong; Chen, Xi; Wu, Yi-Long; Zhou, Qing |
